Microbiome landscape and association with response to immune checkpoint inhibitors in advanced solid tumors: a SCRUM-Japan MONSTAR-SCREEN study
High levels of oral bacteria in the gut may reduce ICI treatment efficacy, especially in patients using PPIs.